The University of Vermont Health Network, along with partners Invitae and LunaPBC, launched a pilot project on November 1, to offer the Genomic DNA Test as part of its clinical care. The test will provide information for 147 genes that are indicators of increased risk for certain diseases including hereditary…

New consensus statements have been released on using platelet function/genetic testing to decide antiplatelet treatment after percutaneous coronary intervention (PCI). As different P2Y12receptor inhibitors (i.e. clopidogrel, prasugrel, and ticagrelor) have been approved for post-PCI treatment more physicians have started prescribing individualized regimens.  An international expert panel’s updated recommendations for such…

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the genetics department at Stanford University. The Stanford group’s pioneering precision health study is published in the May issue of Nature Medicine. To carry out the study,…

HTG Molecular Diagnostics said today it has expanded a 4½-year-old agreement with Illumina allowing for development of in-vitro diagnostic (IVD) test kits for use with the companies’ technologies beyond oncology, to now include autoimmune, cardiovascular, and fibrosis disorders and diseases. The value of the amended agreement was not disclosed. HTG’s…

There is no doubt the age of wearable monitors is upon us. Sales of physical activity monitors have increased dramatically from 15 million in 2014 to 65 million in 2017, according to Statista.com. A 2017 study by Juniper Research estimates that the use of fitness trackers will double by 2021.…

The National Institutes of Health announced a five-year, $3.1 million grant for Geisinger,a s an extension of its MyCode Community Health initiative to research innovative, genomics-based approaches for the early detection of arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC is a degenerative heart disease that is responsible for roughly 20 percent…

An international team of investigators has published new data that suggests that rising temperatures stemming from global climate change may increase the number of infants born with congenital heart defects (CHD) in the United States over the next two decades. “Our findings underscore the alarming impact of climate change on…

Cambridge Epigenetix has launched a discovery and development program for a test to detect colorectal and other cancers, using proceeds from a just-completed $30 million financing round and exclusive patent rights the company has acquired for its epigenetic sequencing platform. The company is developing a detection test for colorectal cancer…

The NIH’s All of Us Research Program has awarded a total $28.6 million to establish three genome centers nationwide. All of Us is the research cohort piece of the Precision Medicine Initiative (PMI) designed to glean health and wellness data from 1 million or more Americans. The funding is intended…

Seqster said today its health data management platform will be integrated with Scripps Research Translational Institute (SRTI)’s MyGeneRank app in a collaboration designed to promote better healthcare decisions by app users through tracking of medications and lifestyle modifications. The collaboration, whose value was not disclosed, was announced at the 2018…

San Diego-based testing company Diagnomics announced it has entered a partnership with pharmacogenomics (PGx) knowledgebase company Translational Software Inc. (TSI). Under the partnership, Diagnomics will deploy TSI’s PGx technology to generate a report on a tested individual’s potential to respond to specific drugs, which drugs should be avoided, and how…

GenomeDx Biosciences said today it will use its Decipher Prostate Cancer Classifier tests, and the database from which they are derived, to test samples from multiple clinical trials by Johnson & Johnson’s Janssen Pharmaceuticals in order to assess prostate cancer candidates. The companies plan to examine the association of prognostic…

Few scientists earn a repeat invitation to keynote the Molecular Medicine Tri-Con (TRICON) event, especially not 23 years apart. But Lee Hood is an exception. Kicking off the 25th anniversary edition of TRICON in San Francisco earlier this week, Hood reflected on his mission to promote “P4 medicine”, illustrating with…

Genome Medical, which bills itself as a national genomics medical practice, has announced it will use the genomic data analysis and reporting services of Fabric Genomics to provide its patients, doctors, and genetic counselors with insight into both targeted treatments and disease prevention. “Genome Medical is the first and only…

Fitbit has been chosen as the first wearable for use in the NIH’s All of Us Research Program, the research cohort piece of the Precision Medicine Initiative (PMI) designed to glean health and wellness data from 1 million or more Americans. As part of All of Us, the Scripps Translational…